Submitted by Anonymous (not verified) on 18 October 2024 - 14:10
Safety and residue data requirements for applications for non-immunological veterinary medicinal products intended for limited markets but not eligible for authorisation under Article 23 of Regulation (EU) 2019/6 - Scientific guideline
Source: